Fraley D S, Adler S
Kidney Int. 1977 Nov;12(5):354-60. doi: 10.1038/ki.1977.122.
Patients having hyperkalemia often are given bicarbonate to raise blood pH and shift extracellular potassium into cells. Blood pH in many hyperkalemic patients, however, is compensated. To determine whether bicarbonate, independent of its pH action, affects plasma potassium, 14 hyperkalemic patients were treated with bicarbonate in 5% dextrose. In five patients (changed pH group), blood pH rose at least 0.08, while in nine (constant pH group), it changed less than 0.04. In the first group, pH rose 0.12, bicarbonate rose 5.9 mEq/liter, and plasma potassium fell 1.6 mEq/liter, and plasma potassium fell 1.4 mEq/liter. The correlation between changes in plasma potassium and bicarbonate was identical in the two groups and independent of urinary potassium excretion. Four additional patients, who were treated with 5% dextrose alone, did not significantly lower their plasma potassium, although subsequent treatment with bicarbonate in 5% dextrose lowered their plasma potassium. Thus, bicarbonate lowers plasma potassium, independent of its effect on blood pH, and despite a risk of volume overload, should be used to treat hyperkalemia in compensated acid-base disorders, even in the presence of renal failure, provided the plasma bicarbonate concentration is decreased.
高钾血症患者常被给予碳酸氢盐以提高血液pH值并使细胞外钾移入细胞内。然而,许多高钾血症患者的血液pH值已得到代偿。为了确定碳酸氢盐在不依赖其pH作用的情况下是否会影响血钾,对14例高钾血症患者给予5%葡萄糖中的碳酸氢盐进行治疗。5例患者(pH值改变组)血液pH值至少升高0.08,而9例患者(pH值恒定组)血液pH值变化小于0.04。在第一组中,pH值升高0.12,碳酸氢盐升高5.9 mEq/升,血钾降低1.6 mEq/升,第二组血钾降低1.4 mEq/升。两组血钾变化与碳酸氢盐之间的相关性相同,且与尿钾排泄无关。另外4例仅接受5%葡萄糖治疗的患者血钾没有显著降低,尽管随后给予5%葡萄糖中的碳酸氢盐治疗后血钾降低。因此,碳酸氢盐可降低血钾,与其对血液pH值的影响无关,并且尽管存在容量超负荷的风险,但在代偿性酸碱紊乱的高钾血症治疗中,即使存在肾衰竭,只要血浆碳酸氢盐浓度降低,仍应使用。